Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Nebraska · 109th Legislature (2025-2026) · Bill

LB 210: Provide for fees and assessments for participation and use of the prescription drug monitoring program and the designated health information exchange

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

LB 210 is a bill introduced in the Nebraska Legislature on January 14, 2025. According to its official title, it concerns: Provide for fees and assessments for participation and use of the prescription drug monitoring program and the designated health information exchange. Primary sponsor: Merv Riepe (Nonpartisan). Most recent recorded action (April 17, 2026): Indefinitely postponed.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Nonpartisan 1

NameRolePartyChamberDistrict
Merv RiepePrimary sponsorNonpartisanLegislature12

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Indefinitely postponed
  2. Title printed. Carryover bill
  3. Notice of hearing for March 06, 2025
  4. Referred to Health and Human Services Committee
  5. Date of introduction

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source